June 14, 2024
Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the proposed merger between the below listed companies.  Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of the company being acquired.  

Kuehn Law is investigating whether the Board of Directors of the target company:

1) acted to maximize shareholder value,
2) failed to disclose material information, and
3) conducted a fair process:  
Kuehn Law is conducting an investigation into the fairness of the proposed sale of Asensus Surgical, Inc. (NYSE: ASXC) to KARL STORZ Endoscopy-America, Inc. for $0.35 per share in cash.